Compare Shopify Inc. (SHOP) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Shopify Inc. vs Tango Therapeutics Inc. — how do they compare? Shopify Inc. trades at $170.07 (market cap $227.12B), while Tango Therapeutics Inc. trades at $22.23 (market cap $3.75B). The key difference: Shopify Inc. is far larger — about 60.6× Tango Therapeutics Inc.'s market cap, and Shopify Inc. is trading nearer its 52-week high, Tango Therapeutics Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Shopify Inc. for 78 Days and Tango Therapeutics Inc. for 0 Days on average.
| SHOP | TNGX | |
|---|---|---|
Market Cap | $227.12B | $3.75B |
Volume | 6,965,160 | 9,619,106 |
Sector | Technology | Health |
52-Week High | $179.22 | $32.90 |
52-Week Low | $95.40 | $7.50 |
Typical Hold Time | 78 Days | 0 Days |
Enterprise Value | $222.35B | $2.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SHOP trades at $172.50, down 3.75% today but maintains a bullish technical outlook with strong moving average support. The company shows robust revenue growth from $5.6B in 2022 to $11.6B in 2025, though valuation ratios remain elevated with a P/E of 119.27. Recent news highlights Shopify's AI innovations including Canvas site-building tool and open AI agent checkout, positioning it favorably against competitors.
Shopify's outlook remains positive with 67% analyst buy ratings and $172.47 consensus target. Key opportunities include AI-driven commerce expansion and merchant solutions growth accelerating to 37%. Risks include high valuation multiples and competitive pressure from Amazon's opposing AI strategy. The stock offers growth potential but requires monitoring of earnings sustainability.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Shopify Inc.
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
